FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029002123> ?p ?o ?g. }

• W2029002123 endingPage "1480" @default.
• W2029002123 startingPage "1473" @default.
• W2029002123 abstract "Abstract Objective To examine whether hydroxychloroquine (HCQ) usage is associated with a reduced risk of damage accrual in patients with systemic lupus erythematosus (SLE). Methods Patients (n = 518) meeting the American College of Rheumatology criteria for diagnosis of SLE and with ≤5 years disease duration at study entry were followed up annually. Socioeconomic, demographic, clinical, and serologic manifestations as well as disease activity (by the Systemic Lupus Activity Measure [SLAM]) and damage (by the Systemic Lupus International Collaborating Clinics damage index [SDI]) were measured. Propensity scores were calculated to adjust for confounding factors affecting treatment assignment. A Cox proportional hazards model was used to compare the risk of developing new damage according to HCQ use at enrollment into the study. Results Fifty‐six percent of the patients were treated with HCQ at the time of study enrollment. Patients who were not treated with HCQ on enrollment had higher SLAM and SDI scores than patients who were treated. Untreated patients were significantly more likely to have major organ involvement such as renal disease ( P < 0.0001) or central nervous system disease ( P < 0.0025). Results of unadjusted analysis suggested that treated patients were less likely to accrue damage (hazard ratio [HR] 0.68). With adjustment for differences in treatment assignment, HCQ usage was still associated with a reduced risk of developing new damage, with an HR of 0.68 (95% confidence interval [95% CI] 0.53–0.93) ( P = 0.014). With adjustment for differences in treatment assignment, HCQ usage was still associated with a reduced risk of developing new damage (HR 0.73 [95% CI 0.52–1.00]) ( P = 0.05). However, patients receiving HCQ who had no damage at study entry had a statistically significant decrease in the risk of damage accrual (HR 0.55 [95% CI 0.34–0.87]) ( P = 0.0111), whereas those receiving HCQ who had damage at study entry did not (HR 1.106 [95% CI 0.70–1.74]) ( P = 0.6630). Conclusion These findings indicate that, after adjustment for propensity to receive HCQ, HCQ usage is independently associated with a reduced risk of damage accrual in SLE patients who had not yet accrued damage at the time of treatment initiation." @default.
• W2029002123 created "2016-06-24" @default.
• W2029002123 creator A5011658566 @default.
• W2029002123 creator A5012863830 @default.
• W2029002123 creator A5021102788 @default.
• W2029002123 creator A5023038788 @default.
• W2029002123 creator A5053566435 @default.
• W2029002123 creator A5063498672 @default.
• W2029002123 creator A5066883334 @default.
• W2029002123 creator A5082825997 @default.
• W2029002123 creator A5090500376 @default.
• W2029002123 date "2005-05-01" @default.
• W2029002123 modified "2023-10-16" @default.
• W2029002123 title "Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual" @default.
• W2029002123 cites W1520498989 @default.
• W2029002123 cites W1561874343 @default.
• W2029002123 cites W157535844 @default.
• W2029002123 cites W167619333 @default.
• W2029002123 cites W1759546812 @default.
• W2029002123 cites W1964598562 @default.
• W2029002123 cites W1965683411 @default.
• W2029002123 cites W1968720144 @default.
• W2029002123 cites W1975619054 @default.
• W2029002123 cites W1978416104 @default.
• W2029002123 cites W1979972482 @default.
• W2029002123 cites W1981501313 @default.
• W2029002123 cites W1982404418 @default.
• W2029002123 cites W1988848567 @default.
• W2029002123 cites W1989924681 @default.
• W2029002123 cites W1992526360 @default.
• W2029002123 cites W1995468535 @default.
• W2029002123 cites W2001641494 @default.
• W2029002123 cites W2002102442 @default.
• W2029002123 cites W2011597257 @default.
• W2029002123 cites W2014893136 @default.
• W2029002123 cites W2016665561 @default.
• W2029002123 cites W2019950575 @default.
• W2029002123 cites W2021741488 @default.
• W2029002123 cites W2022070992 @default.
• W2029002123 cites W2023997415 @default.
• W2029002123 cites W2026678006 @default.
• W2029002123 cites W2027920259 @default.
• W2029002123 cites W2045139782 @default.
• W2029002123 cites W2045511809 @default.
• W2029002123 cites W2049378381 @default.
• W2029002123 cites W2052806549 @default.
• W2029002123 cites W2057696929 @default.
• W2029002123 cites W2065827064 @default.
• W2029002123 cites W2072626440 @default.
• W2029002123 cites W2073018482 @default.
• W2029002123 cites W2077028267 @default.
• W2029002123 cites W2085687924 @default.
• W2029002123 cites W2088340307 @default.
• W2029002123 cites W2090469992 @default.
• W2029002123 cites W2091545883 @default.
• W2029002123 cites W2091679727 @default.
• W2029002123 cites W2107871522 @default.
• W2029002123 cites W2108905161 @default.
• W2029002123 cites W2112032425 @default.
• W2029002123 cites W2114046802 @default.
• W2029002123 cites W2118914856 @default.
• W2029002123 cites W2121690051 @default.
• W2029002123 cites W2125189646 @default.
• W2029002123 cites W2127396740 @default.
• W2029002123 cites W2130001250 @default.
• W2029002123 cites W2131565576 @default.
• W2029002123 cites W2145686360 @default.
• W2029002123 cites W2146203649 @default.
• W2029002123 cites W2154326428 @default.
• W2029002123 cites W2168514602 @default.
• W2029002123 cites W4242308600 @default.
• W2029002123 cites W4368222814 @default.
• W2029002123 cites W3024057897 @default.
• W2029002123 doi "https://doi.org/10.1002/art.21039" @default.
• W2029002123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15880829" @default.
• W2029002123 hasPublicationYear "2005" @default.
• W2029002123 type Work @default.
• W2029002123 sameAs 2029002123 @default.
• W2029002123 citedByCount "318" @default.
• W2029002123 countsByYear W20290021232012 @default.
• W2029002123 countsByYear W20290021232013 @default.
• W2029002123 countsByYear W20290021232014 @default.
• W2029002123 countsByYear W20290021232015 @default.
• W2029002123 countsByYear W20290021232016 @default.
• W2029002123 countsByYear W20290021232017 @default.
• W2029002123 countsByYear W20290021232018 @default.
• W2029002123 countsByYear W20290021232019 @default.
• W2029002123 countsByYear W20290021232020 @default.
• W2029002123 countsByYear W20290021232021 @default.
• W2029002123 countsByYear W20290021232022 @default.
• W2029002123 countsByYear W20290021232023 @default.
• W2029002123 crossrefType "journal-article" @default.
• W2029002123 hasAuthorship W2029002123A5011658566 @default.
• W2029002123 hasAuthorship W2029002123A5012863830 @default.
• W2029002123 hasAuthorship W2029002123A5021102788 @default.
• W2029002123 hasAuthorship W2029002123A5023038788 @default.
• W2029002123 hasAuthorship W2029002123A5053566435 @default.
• W2029002123 hasAuthorship W2029002123A5063498672 @default.

• next